Sivik Global Healthcare LLC Has $5.23 Million Holdings in Encompass Health Corporation (NYSE:EHC)

Sivik Global Healthcare LLC grew its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 14.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 51,600 shares of the company's stock after buying an additional 6,600 shares during the quarter. Encompass Health accounts for about 2.8% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 19th biggest holding. Sivik Global Healthcare LLC owned about 0.05% of Encompass Health worth $5,226,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. lifted its position in shares of Encompass Health by 944.7% in the fourth quarter. Blue Trust Inc. now owns 1,473 shares of the company's stock worth $136,000 after purchasing an additional 1,332 shares in the last quarter. Principal Securities Inc. lifted its position in shares of Encompass Health by 14.4% in the fourth quarter. Principal Securities Inc. now owns 2,207 shares of the company's stock worth $204,000 after purchasing an additional 277 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Encompass Health by 0.5% in the fourth quarter. Principal Financial Group Inc. now owns 299,227 shares of the company's stock worth $27,634,000 after purchasing an additional 1,404 shares in the last quarter. CIBC Asset Management Inc lifted its position in shares of Encompass Health by 5.2% in the fourth quarter. CIBC Asset Management Inc now owns 3,111 shares of the company's stock worth $287,000 after purchasing an additional 154 shares in the last quarter. Finally, Truist Financial Corp lifted its position in shares of Encompass Health by 11.3% in the fourth quarter. Truist Financial Corp now owns 8,684 shares of the company's stock worth $802,000 after purchasing an additional 884 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Stock Performance

NYSE EHC traded down $0.68 on Friday, hitting $119.07. 1,297,450 shares of the stock were exchanged, compared to its average volume of 703,348. Encompass Health Corporation has a 52 week low of $82.74 and a 52 week high of $123.13. The company has a market capitalization of $12.00 billion, a PE ratio of 24.60, a P/E/G ratio of 2.42 and a beta of 0.89. The business's fifty day moving average is $115.81 and its 200 day moving average is $104.00. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. The company's quarterly revenue was up 10.6% on a year-over-year basis. Research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.57%. Encompass Health's dividend payout ratio is currently 14.05%.

Insider Buying and Selling at Encompass Health

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 over the last ninety days. Insiders own 2.10% of the company's stock.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of research reports. Barclays boosted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. UBS Group boosted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Royal Bank Of Canada upped their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Finally, Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Eight analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $127.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.